reported that the independent prognostic capability of the CRP/Alb ratio is noteworthy in individuals with stage III and IV pancreatic carcinoma, but evidently not in patients with pancreatic cancer clinically staged as stage I or II (44). The gene discussed is ALB; the disease is pancreatic neoplasm.